Jason Kelly
Net worth: 22 M $ as of 31/05/2026
Net worth: 22 M $ as of 31/05/2026
Jason Kelly founded Ginkgo Bioworks Holdings, Inc. and Ginkgo Bioworks, Inc. Currently, he holds the position of Chief Executive Officer & Director at Ginkgo Bioworks Holdings, Inc. and Chief Executive Officer & Director at Ginkgo Bioworks, Inc. (a subsidiary of Ginkgo Bioworks Holdings, Inc.). Dr. Kelly is also on the board of Octant, Inc. and Motif Food Works, Inc. In his past career Dr. Kelly was Chief Executive Officer & Director at Soaring Eagle Acquisition Corp. He received an undergraduate degree and a doctorate from Massachusetts Institute of Technology.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2026 | 2,041,437 ( 22.21% ) | 19 M $ | 31/05/2026 | |
| 15/04/2026 | 316,483 ( 0.59% ) | 3 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Founder | 01/01/2008 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Founder | 01/01/2008 |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Director/Board Member | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Board Member | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Director/Board Member | - |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | - |
| Companies | Position | End |
|---|---|---|
| STANDARD BIOTOOLS INC. | Director/Board Member | 01/09/2021 |
| GINO BIOW | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Select your edition
All financial news and data tailored to specific country editions